Inactive Instrument

Highlights Semler Scientific Inc Nasdaq

Equities

US81684M1045

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Earnings Flash (SMLR) SEMLER SCIENTIFIC Posts Q4 Revenue $15.1M, vs. Street Est of $14.5M	Mar. 05	MT
Semler Scientific, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 05	CI
Tranche Update on Semler Scientific, Inc.'s Equity Buyback Plan announced on March 14, 2022.	Nov. 13	CI
Semler Scientific, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Earnings Flash (SMLR) SEMLER SCIENTIFIC Reports Q3 Revenue $16.3M, vs. Street Est of $15.2M	Nov. 09	MT
Earnings Flash (SMLR) SEMLER SCIENTIFIC Reports Q2 Revenue $18.6M, vs. Street Est of $16M	23-08-10	MT
Semler Scientific, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Tranche Update on Semler Scientific, Inc.'s Equity Buyback Plan announced on March 14, 2022.	23-08-09	CI
Semler Scientific, Inc. Provides Revenue Guidance for the Second Quarter Ending June 30, 2023	23-07-11	CI
Earnings Flash (SMLR) SEMLER SCIENTIFIC Reports Q1 Revenue $18.2M	23-05-10	MT
Semler Scientific, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Tranche Update on Semler Scientific, Inc.'s Equity Buyback Plan announced on March 14, 2022.	23-05-09	CI
Semler Scientific, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-03-21	CI
Tranche Update on Semler Scientific, Inc.'s Equity Buyback Plan announced on March 14, 2022.	23-03-21	CI
Semler Scientific, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-03-21	CI
Earnings Flash (SMLR) SEMLER SCIENTIFIC Reports Q4 Revenue $13.8M, vs. Street Est of $13.1M	23-03-21	MT
Semler Scientific, Inc. Announces Major Clinical Study Using Semler's QuantaFlo® for Medicare Advantage Beneficiaries, Demonstrates that National, In-Home Screening for Peripheral Artery Disease is Feasible	22-12-14	CI
Tranche Update on Semler Scientific, Inc.'s Equity Buyback Plan announced on March 14, 2022.	22-11-01	CI
Semler Scientific, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-01	CI
Earnings Flash (SMLR) SEMLER SCIENTIFIC Reports Q3 Revenue $14M	22-11-01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Semler Scientific Inc Nasdaq

Equities

US81684M1045

Highlights

Filters